The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
about
Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein responseRegulation of unfolded protein response modulator XBP1s by acetylation and deacetylationBlockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaDivergent allosteric control of the IRE1α endoribonuclease using kinase inhibitorsIdentification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicingPotent and selective inhibitors of the inositol-requiring enzyme 1 endoribonucleaseInitial genome sequencing and analysis of multiple myelomaPrognostic significance of copy-number alterations in multiple myelomaXBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cellsCancer Microenvironment and Endoplasmic Reticulum Stress ResponseFactors regulating immunoglobulin production by normal and disease-associated plasma cellsA novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic diseaseDivergent effects of PERK and IRE1 signaling on cell viabilityStructure of the Dual Enzyme Ire1 Reveals the Basis for Catalysis and Regulation in Nonconventional RNA SplicingNovel therapeutic strategies for multiple myelomaInflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologiesOsteolytica: An automated image analysis software package that rapidly measures cancer-induced osteolytic lesions in in vivo models with greater reproducibility compared to other commonly used methodsCharacterization of a novel mouse model of multiple myeloma and its use in preclinical therapeutic assessmentMndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibilitySelective inhibition of tumor oncogenes by disruption of super-enhancersMolecular mechanisms of human IRE1 activation through dimerization and ligand binding(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.ER stress affects processing of MHC class I-associated peptides.Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells.The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myelomaRegulation of basal cellular physiology by the homeostatic unfolded protein responseXBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injuryBone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.Endoplasmic reticulum stress is chronically activated in chronic pancreatitisDinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanismCancer stem cells: controversies in multiple myelomaStimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells.Enhancer alterations in cancer: a source for a cell identity crisis.Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells.New insights, recent advances, and current challenges in the biological treatment of multiple myeloma.
P2860
Q24292966-A65C456F-BD0C-458A-BF5B-B3B6082A4195Q24303825-AB31FBDE-FDEB-40E6-83F0-EBAEDE5F53FAQ24598483-61BEDC52-64BE-459C-BE5D-34B6D24C7A78Q24606387-16FB2CE0-3CFE-465F-864F-2A31B69DCC05Q24627782-E4B4E6A1-83AF-495E-A7C3-300404A3CCC1Q24628936-D0079C01-62AD-4425-9572-18C8DF123BB5Q24629117-9E5823B1-5820-44AD-B431-E231E215E244Q24643402-E4635B13-EDCA-4C93-8CA0-3A1B77038044Q24658399-39E31E82-CB4C-4144-9CD5-F8E285B86B09Q26778533-8830BCBD-624C-41C7-915E-34A0F162E9B4Q27021855-9DE39855-C7EF-4A9A-B5BC-16F9BBBA4380Q27329429-678CEAB4-5B7F-4134-8A86-C534FECA9CEBQ27438124-9458AD41-5BF8-4222-B5B9-E077D686C1F8Q27649529-9C156BB0-C8C9-452E-8AEE-77A6B91B879DQ28081590-FA55E510-827F-4766-9388-BD1D8B0A53DDQ28236897-8603EEED-E6FB-4C1F-AA33-4B7D8E69CB09Q28364664-BDB852EE-3A58-401B-9769-7889A6A91EDFQ28486349-5B06115F-2317-4646-82C2-7084E62E52BAQ28593570-0F9D14CC-FFC5-46EB-B7AC-0A2C196309C3Q29617301-F610F09D-EBF5-4524-B5F7-91B5C2619A91Q30404387-CE54F836-F0A5-4986-A829-64B352D37804Q30561836-926E4C59-710B-47E3-9BA5-12DEFC49FFA3Q33409763-12283550-7B1A-470C-9259-CC7B2293B095Q33471405-93BB0004-9921-473C-8264-0D3267849A73Q33834752-4F68012B-6147-4B65-9675-88AEDF5BB098Q33838260-FE63533B-0375-4E5E-B9FD-C15DA5D40F19Q33886820-1467B6E2-D349-41E7-8A87-71C530DB4857Q33926690-E7ABC320-2BD2-42CD-AFC5-A5FE4C484533Q33931176-03CA39AD-1CBA-4447-AAD8-87FCE42CBD4AQ34056196-EFB18912-1A1D-4E40-ACFD-C59594D14104Q34155848-20626016-2739-45C3-B499-188BE91ACB87Q34168461-DC48A032-6FF5-4E20-A392-33CFE3FE495FQ34283421-3A25E1E7-F057-478C-9227-742E88B232A4Q34393767-C3F7835F-7520-4156-B61E-933930072D3FQ34462722-671F08EA-62CB-4FC3-8D15-09F1BF591AE6Q34508337-D684150E-BADD-4B94-BD57-CD2F97481AC9Q34606889-9C439FAD-35A5-4F8B-AA42-9D377A3DBA1CQ34624854-7517EF45-BA8B-4D4F-910F-3B907367571EQ34661930-0A2C775D-15F1-4DB4-9BF5-FA907C37376DQ34773850-C1CFBC92-2DB4-4D66-BCA6-922C1B3DE759
P2860
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The differentiation and stress ...... multiple myeloma pathogenesis.
@ast
The differentiation and stress ...... multiple myeloma pathogenesis.
@en
type
label
The differentiation and stress ...... multiple myeloma pathogenesis.
@ast
The differentiation and stress ...... multiple myeloma pathogenesis.
@en
prefLabel
The differentiation and stress ...... multiple myeloma pathogenesis.
@ast
The differentiation and stress ...... multiple myeloma pathogenesis.
@en
P2093
P2860
P1433
P1476
The differentiation and stress ...... multiple myeloma pathogenesis.
@en
P2093
Alexei Protopopov
Daniel E Carrasco
Daniel R Carrasco
Elena V Ivanova
Geraldine S Pinkus
Giovanni Tonon
James Horner
Joel Henderson
Kumar Sukhdeo
P2860
P304
P356
10.1016/J.CCR.2007.02.015
P577
2007-04-01T00:00:00Z